There May Be Underlying Issues With The Quality Of Astrana Health's (NASDAQ:ASTH) Earnings
There May Be Underlying Issues With The Quality Of Astrana Health's (NASDAQ:ASTH) Earnings
Investors were disappointed with Astrana Health, Inc.'s (NASDAQ:ASTH) earnings, despite the strong profit numbers. We did some digging and found some worrying underlying problems.
投资者对Astrana Health,Inc.(纳斯达克:ASTH)的收益感到失望,尽管利润数字强劲。我们进行了一些调查,并发现了一些令人担忧的潜在问题。
One essential aspect of assessing earnings quality is to look at how much a company is diluting shareholders. Astrana Health expanded the number of shares on issue by 10% over the last year. Therefore, each share now receives a smaller portion of profit. Per share metrics like EPS help us understand how much actual shareholders are benefitting from the company's profits, while the net income level gives us a better view of the company's absolute size. You can see a chart of Astrana Health's EPS by clicking here.
评估收益质量的一个重要方面是看公司对股东进行了多少摊薄。Astrana Health在过去一年中扩大了发行股份数量10%。因此,现在每股获利较少。每股指标如EPS帮助我们了解实际股东从公司利润中受益的程度,而净利润水平则让我们更好地了解公司的绝对规模。您可以点击这里查看Astrana Health的EPS图表。
How Is Dilution Impacting Astrana Health's Earnings Per Share (EPS)?
股东股东Astrana Health的每股收益(EPS)受到摊薄的影响如何?
Astrana Health's net profit dropped by 11% per year over the last three years. The good news is that profit was up 40% in the last twelve months. But EPS was less impressive, up only 37% in that time. Therefore, the dilution is having a noteworthy influence on shareholder returns.
过去三年中,Astrana Health的净利润年均下降了11%。好消息是,过去十二个月利润增长了40%。但是EPS增长并不那么令人印象深刻,在那段时间仅增长了37%。因此,摊薄对股东回报产生了显着影响。
Changes in the share price do tend to reflect changes in earnings per share, in the long run. So Astrana Health shareholders will want to see that EPS figure continue to increase. But on the other hand, we'd be far less excited to learn profit (but not EPS) was improving. For that reason, you could say that EPS is more important that net income in the long run, assuming the goal is to assess whether a company's share price might grow.
股价的变化通常反映了长期内每股收益的变化。因此,Astrana Health的股东希望看到EPS数字继续增长。但另一方面,了解利润(但不了解EPS)正在提高我们会感到远没有那么兴奋。基于这个原因,可以说在长期内,EPS比净利润更重要,假设目标是评估一家公司的股价是否可能增长。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
这可能会让您想知道分析师对未来盈利能力的预测。幸运的是,您可以单击此处查看基于其估计的未来盈利能力的互动图表。
Our Take On Astrana Health's Profit Performance
我们对Astrana Health利润表现的看法
Astrana Health shareholders should keep in mind how many new shares it is issuing, because, dilution clearly has the power to severely impact shareholder returns. Therefore, it seems possible to us that Astrana Health's true underlying earnings power is actually less than its statutory profit. But at least holders can take some solace from the 37% EPS growth in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you want to do dive deeper into Astrana Health, you'd also look into what risks it is currently facing. Every company has risks, and we've spotted 1 warning sign for Astrana Health you should know about.
Astrana Health股东应牢记公司正在发行的新股数量,因为稀释显然有可能严重影响股东回报。因此,我们认为Astrana Health真正的基本盈利能力实际上可能低于其法定利润。但至少股东可以从去年37%的每股收益增长中获得一些安慰。本文的目标是评估我们能否依赖法定收益来反映公司的潜力,但还有很多要考虑的因素。如果您想深入了解Astrana Health,还应该研究目前面临的风险。每家公司都有风险,我们已经发现了一个有关Astrana Health的警告信号,您应该知道。
Today we've zoomed in on a single data point to better understand the nature of Astrana Health's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
今天,我们将重点放在一个数据点上,以更好地了解Astrana Health的利润性质。但如果您能集中注意力关注细节,您总能发现更多。例如,许多人认为高净资产回报率是有利的商业经济指标,而其他人则喜欢“追踪资金”并寻找内部人员正在购买的股票。虽然这可能需要您进行一些研究,但您可能会发现这些具有高净资产回报率的公司的免费收藏,或这些持有重大内部持股的股票清单是有用的。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。